Glypican-3 (GPC3) signaling pathway involved in breast cancer progression

被引：0
|
作者：
Fernandez, Dolores [1 ]
Cercato, Magali [1 ]
Guereno, Macarena [1 ]
Peters, Maria G. [1 ]
机构：
[1] Angel H Roffo Inst Oncol, Buenos Aires, DF, Argentina
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4508
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Glypican-3 (GPC3) modulates senescence, homotypic adhesion and migration of tumor mammary cells through the inhibition of the canonical Wnt pathway
    Lago Huvelle, Maria A.
    Buchanan, Cecilia
    Romero, Silvina A.
    de Kier Joffe, Elisa Bal
    Giselle Peters, Maria
    CANCER RESEARCH, 2011, 71
  • [22] Proof of glypican-3 (GPC3) peptide specific CTLs infiltrating into tumor tissue derived from advanced HCC patient vaccinated with GPC3 peptide.
    Yoshikawa, Toshiaki
    Sakai, Mayuko
    Ofuji, Kazuya
    Takahashi, Mari
    Shimomura, Manami
    Sawada, Yu
    Nobuoka, Daisuke
    Nakatsura, Tetsuya
    CANCER RESEARCH, 2013, 73
  • [23] GLYPICAN-3 PROMOTES HEPATOCELLULAR CARCINOMA PROGRESSION AND METASTASIS BY ACTIVATION OF THE ERK SIGNALING PATHWAY
    Wu, Y.
    Liu, H.
    Weng, H.
    Zhang, X.
    Li, P.
    Fan, C.
    Li, B.
    Dong, P.
    Li, L.
    Dooley, S.
    Ding, H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S429 - S430
  • [24] Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3
    Zhu, Xiao-ting
    Yuan, Ji-hang
    Zhu, Teng-teng
    Li, Yang-yang
    Cheng, Xiao-yang
    FEBS JOURNAL, 2016, 283 (20) : 3739 - 3754
  • [25] Somatic glypican 3 (GPC3) mutations in Wilms' tumour
    White, GRM
    Kelsey, AM
    Varley, JM
    Birch, JM
    BRITISH JOURNAL OF CANCER, 2002, 86 (12) : 1920 - 1922
  • [26] Somatic glypican 3 (GPC3) mutations in Wilms' tumour
    G R M White
    A M Kelsey
    J M Varley
    J M Birch
    British Journal of Cancer, 2002, 86 : 1920 - 1922
  • [27] Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway
    Dolores Fernández
    Macarena Guereño
    María Amparo Lago Huvelle
    Magalí Cercato
    María Giselle Peters
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2399 - 2418
  • [28] Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway
    Fernandez, Dolores
    Guereno, Macarena
    Lago Huvelle, Maria Amparo
    Cercato, Magali
    Giselle Peters, Maria
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (12) : 2399 - 2418
  • [29] Differential expression of glypican-3 (GPC3) in lung squamous cell carcinoma and lung adenocarcinoma and its clinical significance
    Yu, X.
    Li, Y.
    Chen, S. W.
    Shi, Y.
    Xu, F.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 10185 - 10192
  • [30] The over-activation of Akt1 oncogene heightens the Glypican-3 (GPC3) effects on metastatic progression of murine mammary tumor cells
    Romero, Silvina A.
    Lago Huvelle, Maria A.
    Peluffo, Guillermo D.
    de Kier Joffe, Elisa Bal
    Urtreger, Alejandro J.
    Peters, Maria G.
    CANCER RESEARCH, 2012, 72
12345